NYSE:THQ - Tekla Healthcare Opportunities Fund Stock Price, Forecast & News

Tekla Healthcare Opportunities Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "THQ."

Tekla Healthcare Opportunities Fund announced a monthly dividend on Tuesday, February 11th. Investors of record on Thursday, February 20th will be given a dividend of $0.1125 per share on Friday, February 28th. This represents a $1.35 annualized dividend and a dividend yield of 7.04%. The ex-dividend date is Wednesday, February 19th. View Tekla Healthcare Opportunities Fund's Dividend History.

Media headlines about THQ stock have trended somewhat positive this week, InfoTrie reports. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tekla Healthcare Opportunities Fund earned a news impact score of 0.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Tekla Healthcare Opportunities Fund.

Some companies that are related to Tekla Healthcare Opportunities Fund include 1ST TR ENERGY I/SH (FIF), 3i Group (TGOPF), Aberdeen Australia Equity Fund (IAF), Ackermans & van Haaren (ACKB), Advent Claymore Convertible Sec & Inc Fd (AVK), Allianzgi Diversified Incm and Cnvrtb Fd (ACV), AllianzGI Equity & Convertible Income FD (NIE), Alpine Global Premier Properties Fund (AWP), Alternative Invest Ordinary Units FP (AIQ), Amedeo Resources (AMED), Apollo Senior Floating Rate Fund (AFT), Azimut (AZIHF), Bankinter (BKT), Barings Global Short Duratin Hgh Yld Fnd (BGH) and BlackRock Core Bond Trust (BHK).

Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Healthcare Opportunities Fund investors own include Gilead Sciences (GILD), Verizon Communications (VZ), Walgreens Boots Alliance (WBA), Altria Group (MO), Exxon Mobil (XOM), Cisco Systems (CSCO), Apple Hospitality REIT (APLE), BlackRock Enhanced Dividend Achievers Tr (BDJ), Enbridge (ENB) and Tekla Healthcare Investors (HQH).

Tekla Healthcare Opportunities Fund's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Raymond James & Associates (0.00%), Raymond James Financial Services Advisors Inc. (0.00%), UBS Group AG (0.00%), Cornerstone Advisors LLC (0.00%), Advisors Asset Management Inc. (0.00%) and Wedbush Securities Inc. (0.00%). View Institutional Ownership Trends for Tekla Healthcare Opportunities Fund.

THQ stock was sold by a variety of institutional investors in the last quarter, including Advisors Asset Management Inc., Stifel Financial Corp, StrategIQ Financial Group LLC, Raymond James & Associates and PNC Financial Services Group Inc.. View Insider Buying and Selling for Tekla Healthcare Opportunities Fund.

THQ stock was purchased by a variety of institutional investors in the last quarter, including Cornerstone Advisors LLC, Marks Group Wealth Management Inc, Landscape Capital Management L.L.C., Raymond James Financial Services Advisors Inc., Steward Partners Investment Advisory LLC, Advisory Services Network LLC, Vigilare Wealth Management and Janney Montgomery Scott LLC. View Insider Buying and Selling for Tekla Healthcare Opportunities Fund.

Shares of THQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of THQ stock can currently be purchased for approximately $19.17.

The official website for Tekla Healthcare Opportunities Fund is http://www.teklacap.com/.

Tekla Healthcare Opportunities Fund's mailing address is 100 Federal St Fl 19, BOSTON, MA 02110-1831, United States. The company can be reached via phone at +1-617-7728500.